Liu Jun Zi Tang—A Potential, Multi-Herbal Complementary Therapy for Chemotherapy-Induced Neurotoxicity

Chun-Tang Chiou,Kaw-Chen Wang,Ying-Chen Yang,Chuen-Lin Huang,Sien-Hung Yang,Yao-Haur Kuo,Nai-Kuei Huang
DOI: https://doi.org/10.3390/ijms19041258
IF: 5.6
2018-04-23
International Journal of Molecular Sciences
Abstract:Liu Jun Zi Tang (LJZT) has been used to treat functional dyspepsia and depression, suggesting its effects on gastrointestinal and neurological functions. LJZT is currently used as a complementary therapy to attenuate cisplatin-induced side effects, such as dyspepsia. However, its effect on chemotherapy-induced neuropathic pain or neurotoxicity has rarely been studied. Thus, we explored potential mechanisms underlying LJZT protection against cisplatin-induced neurotoxicity. We observed that LJZT attenuated cisplatin-induced thermal hyperalgesia in mice and apoptosis in human neuroblastoma SH-SY5Y cells. Furthermore, it also attenuated cisplatin-induced cytosolic and mitochondrial free radical formation, reversed the cisplatin-induced decrease in mitochondrial membrane potential, and increased the release of mitochondrial pro-apoptotic factors. LJZT not only activated the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (<i>PGC-1&amp;alpha;</i>) promoter region, but also attenuated the cisplatin-induced reduction of <i>PGC-1&amp;alpha;</i> expression. Silencing of the <i>PGC-1&amp;alpha;</i> gene counteracted the protection of LJZT. Taken together, LJZT mediated, through anti-oxidative effect and mitochondrial function regulation, to prevent cisplatin-induced neurotoxicity.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?